Product news

Share this article:
Bentley Pharmaceuticals announced its European subsidiaries have received approvals to market their omeprazole capsule products, through their licensees, in various territories in Europe. The approvals are for 10 mg. 20 mg. and 40 mg. dosage levels of omeprazole capsules under a Mutual Recognition Procedure (MRP) that grants simultaneous authorizations throughout the EU. Bentley's subsidiaries expect to supply omeprazole to their licensees in the major markets of Germany and Italy, as well as other EU countries. Omeprazole is marketed in the US under the trade name Prilosec by AstraZeneca and under the trade name Losec in Europe.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.